XML 95 R74.htm IDEA: XBRL DOCUMENT v3.24.3
EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Net Income for Earnings Per Share Calculations:        
Income from continuing operations, net of tax $ 362.1 $ 334.9 $ 1,051.0 $ 886.9
Net loss attributable to noncontrolling interest (1.4) (1.2) (3.6) (2.8)
Income from continuing operations attributable to Edwards Lifesciences Corporation 363.5 336.1 1,054.6 889.7
Income from discontinued operations 2,707.3 48.8 2,734.4 142.8
Net income attributable to Edwards Lifesciences Corporation $ 3,070.8 $ 384.9 $ 3,789.0 $ 1,032.5
Weighted Average Shares:        
Basic weighted-average shares outstanding (in shares) 597.2 607.0 600.3 607.2
Dilutive effect of stock plans (in shares) 0.9 2.5 1.9 3.0
Dilutive weighted-average shares outstanding (in shares) 598.1 609.5 602.2 610.2
Basic:        
Continuing operations (in dollars per share) $ 0.61 $ 0.55 $ 1.76 $ 1.47
Discontinued operations (in dollars per share) 4.53 0.08 4.55 0.23
Basic earnings per share (in dollars per share) 5.14 0.63 6.31 1.70
Diluted:        
Continuing operations (in dollars per share) 0.61 0.55 1.75 1.46
Discontinued operations (in dollars per share) 4.52 0.08 4.54 0.23
Diluted earnings per share (in dollars per share) $ 5.13 $ 0.63 $ 6.29 $ 1.69